Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:11073571rdf:typepubmed:Citationlld:pubmed
pubmed-article:11073571lifeskim:mentionsumls-concept:C0001041lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C1442445lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C0030685lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C0450442lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C1999177lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C0680255lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C0391871lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C1283071lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C1963578lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C1611588lld:lifeskim
pubmed-article:11073571lifeskim:mentionsumls-concept:C0674996lld:lifeskim
pubmed-article:11073571pubmed:issue23lld:pubmed
pubmed-article:11073571pubmed:dateCreated2001-1-4lld:pubmed
pubmed-article:11073571pubmed:abstractText2-Fluoro-4-methylpyridine (3) is efficiently functionalized by chlorination, hydrolysis and methanesulfonylation into the novel alkylating agent 7. This mesylate is used for the bisalkylation of anthrone under carefully defined conditions to prepare the cognition enhancer drug candidate 1. This process proceeds in up to 37% overall yield and is adaptable for large scale synthesis.lld:pubmed
pubmed-article:11073571pubmed:languageenglld:pubmed
pubmed-article:11073571pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11073571pubmed:citationSubsetIMlld:pubmed
pubmed-article:11073571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11073571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11073571pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:11073571pubmed:statusMEDLINElld:pubmed
pubmed-article:11073571pubmed:monthNovlld:pubmed
pubmed-article:11073571pubmed:issn0022-3263lld:pubmed
pubmed-article:11073571pubmed:authorpubmed-author:YinJJlld:pubmed
pubmed-article:11073571pubmed:authorpubmed-author:HornJ SJSlld:pubmed
pubmed-article:11073571pubmed:authorpubmed-author:EarlR ARAlld:pubmed
pubmed-article:11073571pubmed:authorpubmed-author:XingYYlld:pubmed
pubmed-article:11073571pubmed:authorpubmed-author:FortunakJ MJMlld:pubmed
pubmed-article:11073571pubmed:authorpubmed-author:PestiJ AJAlld:pubmed
pubmed-article:11073571pubmed:issnTypePrintlld:pubmed
pubmed-article:11073571pubmed:day17lld:pubmed
pubmed-article:11073571pubmed:volume65lld:pubmed
pubmed-article:11073571pubmed:ownerNLMlld:pubmed
pubmed-article:11073571pubmed:authorsCompleteYlld:pubmed
pubmed-article:11073571pubmed:pagination7718-22lld:pubmed
pubmed-article:11073571pubmed:dateRevised2004-11-17lld:pubmed
pubmed-article:11073571pubmed:meshHeadingpubmed-meshheading:11073571...lld:pubmed
pubmed-article:11073571pubmed:meshHeadingpubmed-meshheading:11073571...lld:pubmed
pubmed-article:11073571pubmed:meshHeadingpubmed-meshheading:11073571...lld:pubmed
pubmed-article:11073571pubmed:meshHeadingpubmed-meshheading:11073571...lld:pubmed
pubmed-article:11073571pubmed:year2000lld:pubmed
pubmed-article:11073571pubmed:articleTitleEfficient pyridinylmethyl functionalization: synthesis of 10, 10-Bis[(2-fluoro-4-pyridinyl)methyl]-9(10H)-anthracenone (DMP 543), an acetylcholine release enhancing agent.lld:pubmed
pubmed-article:11073571pubmed:affiliationChemical and Physical Sciences Department, The DuPont Pharmaceuticals Company, Experimental Station, Wilmington, Delaware 19880-0500, USA. jaan.a.pesti@dupontpharma.comlld:pubmed
pubmed-article:11073571pubmed:publicationTypeJournal Articlelld:pubmed